Are you Dr. Proud?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
850 Southampton Ave
Norfolk, VA 23510Phone+1 757-668-9920Fax+1 757-668-9930
Summary
- Dr. Crystal Proud, MD is a Child Neurologist in Norfolk, Virginia. She is currently licensed to practice medicine in Virginia, North Carolina, and California. She is affiliated with Children's Hospital of The King's Daughters.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Child Neurology, 2011 - 2014
Emory University School of MedicineResidency, Pediatrics, 2009 - 2011
Eastern Virginia Medical SchoolClass of 2009
Certifications & Licensure
CA State Medical License 2011 - Present
VA State Medical License 2015 - 2026
NC State Medical License 2022 - 2025- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Publications & Presentations
PubMed
- Spinal Muscular Atrophy Update in Best Practices: Recommendations for Treatment Considerations.Mary K Schroth, Jennifer Deans, Diana X Bharucha Goebel, W Bryan Burnette, Basil T Darras
Neurology. Clinical Practice. 2025-02-01 - 9 citationsCombination disease-modifying treatment in spinal muscular atrophy: A proposed classification.Crystal M Proud, Eugenio Mercuri, Richard S Finkel, Janbernd Kirschner, Darryl C De Vivo
Annals of Clinical and Translational Neurology. 2023-11-01 - 27 citationsA Combined Prospective and Retrospective Comparison of Long-Term Functional Outcomes Suggests Delayed Loss of Ambulation and Pulmonary Decline with Long-Term Eteplirse...Olga Mitelman, Hoda Z. Abdel-Hamid, Barry J. Byrne, Anne M. Connolly, Peter Heydemann
Journal of Neuromuscular Diseases. 2021-08-19
Press Mentions
Gene Therapy from Novartis Shows Promise for Children with SMAJanuary 2nd, 2025- Novartis Intrathecal Onasemnogene Abeparvovec Phase III Study Meets Primary Endpoint in Children, Young Adults with Spinal Muscular AtrophyDecember 30th, 2024
